Abstract
The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 61-66 |
| Number of pages | 6 |
| Journal | International Journal of Cardiovascular Interventions |
| Volume | 5 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2003 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Abciximab
- Angioplasty
- Carotid stent
- Hyperperfusion
Fingerprint
Dive into the research topics of 'Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS